Tags: chemotherapycarboplatincisplatincancerlong-term
Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | <em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. | Circumventing Cancer Resistance - 6 days ago | |
2 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | SABCS 2024: Anthracyclines May Improve Survival in High-Risk Breast Cancer, But Risks Must Be Weighed - 10 days ago Novel Chemotherapy Method Could Decrease Lung Cancer Tumor Size - 10 months ago | |
3 | Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. | ||
4 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | ||
5 | Meghana Keshavan STAT News Biotech nerd and writer @statnews. | ||
6 | Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California | ||
7 | Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. | ||
8 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
9 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 6 months ago First-Line Nivolumab Plus Chemo Approved for Bladder Cancer - 10 months ago Novel Therapy Promising for Radiation-Induced Oral Mucositis - 10 months ago Futile Immunotherapy for Cancer Grows More Common - 12 months ago | |
10 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | KEYNOTE-A18 Data Are 'Practice-Changing' for Cervical Cancer - about 1 year ago Uterine Cancer Trials Made Waves This Year, Experts Say - about 1 year ago |